The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Acceleron Pharma Inc. | COM | 00434H108 | 10,899 | 278,753 | SH | SOLE | 278,753 | 0 | 0 | ||
| Achaogen, Inc. | COM | 004449104 | 36,908 | 2,850,000 | SH | SOLE | 2,850,000 | 0 | 0 | ||
| Achaogen, Inc. | COM | 004449954 | 2,600 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
| Aclaris Therapeutics, Inc. | COM | 00461U105 | 5,473 | 312,368 | SH | SOLE | 312,368 | 0 | 0 | ||
| Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 105,813 | 1,950,477 | SH | SOLE | 1,950,477 | 0 | 0 | ||
| Aimmune Therapeutics, Inc. | COM | 00900T107 | 29,762 | 935,020 | SH | SOLE | 935,020 | 0 | 0 | ||
| Alder BioPharmaceuticals, Inc. | COM | 014339105 | 37,365 | 2,942,130 | SH | SOLE | 2,942,130 | 0 | 0 | ||
| Arcus Biosciences, Inc. | COM | 03969F109 | 42,080 | 3,445,461 | SH | SOLE | 3,445,461 | 0 | 0 | ||
| Ardelyx Inc. | COM | 039697107 | 1,028 | 203,592 | SH | SOLE | 203,592 | 0 | 0 | ||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 19,751 | 302,009 | SH | SOLE | 302,009 | 0 | 0 | ||
| Audentes Therapeutics, Inc. | COM | 05070R104 | 9,476 | 315,331 | SH | SOLE | 315,331 | 0 | 0 | ||
| BioDelivery Sciences International, Inc. | COM | 09060J106 | 338 | 150,004 | SH | SOLE | 150,004 | 0 | 0 | ||
| Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 2,723 | 105,706 | SH | SOLE | 105,706 | 0 | 0 | ||
| Blueprint Medicines Corporation | COM | 09627Y109 | 36,680 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| CymaBay Therapeutics, Inc. | COM | 23257D103 | 20,291 | 1,562,040 | SH | SOLE | 1,562,040 | 0 | 0 | ||
| Epizyme, Inc. | COM | 29428V104 | 17,719 | 998,278 | SH | SOLE | 998,278 | 0 | 0 | ||
| Immunomedics, Inc. | COM | 452907108 | 39,447 | 2,700,000 | SH | SOLE | 2,700,000 | 0 | 0 | ||
| Myokardia, Inc. | COM | 62857M105 | 19,168 | 392,789 | SH | SOLE | 392,789 | 0 | 0 | ||
| Ra Pharmaceuticals, Inc. | COM | 74933V108 | 266 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| Sangamo Therapeutics, Inc. | COM | 800677106 | 2,935 | 154,462 | SH | SOLE | 154,462 | 0 | 0 | ||
| Solid Biosciences Inc. | COM | 83422E105 | 2,020 | 337,884 | SH | SOLE | 337,884 | 0 | 0 | ||
| Tocagen, Inc. | COM | 888846102 | 1,760 | 148,552 | SH | SOLE | 148,552 | 0 | 0 | ||
| Verona Pharma Plc | SPONSORED ADS | 925050106 | 11,306 | 565,292 | SH | SOLE | 565,292 | 0 | 0 | ||
| WAVE Life Sciences Ltd. | SHS | Y95308105 | 3,008 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||